ALT vs DD · rev $20.0K vs P/E 127, rev $12.39B
Altimmune Inc (ALT) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
ALT currently screens at market cap $527.0M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the ALT and DD stock pages for the full models.
Not investment advice.